TITLE

Hepatocyte growth factor gene therapy accelerates regeneration in cirrhotic mouse livers after hepatectomy

AUTHOR(S)
Xue, F.; Takahara, T.; Yata, Y.; Kuwabara, Y.; Shinno, E.; Nonome, K.; Minemura, M.; Takahara, S.; Li, X.; Yamato, E.; Watanabe, A.
PUB. DATE
May 2003
SOURCE
Gut;May2003, Vol. 52 Issue 5, p694
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Impaired regeneration and dysfunction of the cirrhotic liver following partial hepatectomy (PHx) are the most serious risk factors for postoperative liver failure. Aims: Using naked hepatocyte growth factor (HGF) plasmid by the electroporation (EP) in vivo method, we investigated HGF for its role and mechanism of proliferation and restoration of liver mass in cirrhotic mice following PHx. Animals: Eight week old female mice were used. Methods: HGF plasmid 50 µg was injected intramuscularly and transferred by EP in vivo once a week for three weeks. After establishment of carbon tetrachloride induced cirrhosis, mice underwent PHx. The HGF treated group was given naked HGF plasmid four days before PHx, and additional HGF was given once a week until they were killed, while a control group was given only empty plasmid. Mice were killed 2, 4, 10, and 14 days after PHx. Morphological and functional restoration of the liver were examined, as well as activation of mitogen activated protein kinase (MAPK) and mRNA levels of HGF activator (HGFA). Results: The HGF treated group demonstrated a continuous threefold increase in HGF levels in plasma. Therapy with HGF in cirrhotic PHx resulted in effective liver regeneration via restoration of HGFA and activation of MAPK p44/p42, accelerated normalisation of liver function, and increased collagen degradation. Conclusions: HGF gene therapy by in vivo EP may be useful for hepatic resection in cirrhotic livers by stimulating liver proliferative and collagenolytic capacities, as well as accelerating functional recovery.
ACCESSION #
9737024

 

Related Articles

  • Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Ueki, Takahiro; Kaneda, Yasufumi; Tsutsui, Hiroko; Nakanishi, Kenji; Sawa, Yoshiki; Morishita, Ryuichi; Matsumoto, Kunio; Nakamura, Toshikazu; Takahashi, Hiroshi; Okamoto, Eizo; Fujimoto, Jiro // Nature Medicine;Feb99, Vol. 5 Issue 2, p226 

    Liver cirrhosis is the irreversible end result of fibrous scarring and hepatocellular regeneration, characterized by diffuse disorganization of the normal hepatic structure of regenerative nodules and fibrotic tissue. It is associated with prominent morbidity and mortality, and is induced by...

  • Hepatocyte growth factor gene therapy retards the progression of chronic obstructive nephropathy. Gao, Xiaojie; Mae, Hiromu; Ayabe, Nobuhiko; Takai, Toru; Oshima, Keisuke; Hattori, Masuji; Ueki, Takahiro; Fujimoto, Jiro; Tanizawa, Takakuni // Kidney International;Oct2002, Vol. 62 Issue 4, p1238 

    Hepatocyte growth factor gene therapy retards the progression of chronic obstructive nephropathy. Background. Unilateral ureteral obstruction (UUO) is characterized by progressive tubular atrophy and interstitial fibrosis. Rupture of the balance between cell proliferation and apoptosis plays a...

  • Last orders. Boyce, Nell // New Scientist;02/06/99, Vol. 161 Issue 2172, p16 

    Investigates research into the effects of hepatocyte growth factor (HGF) on fatty liver disease and cirrhosis caused by excessive alcohol intake. What the diseases are, how they affect the body, and what treatments are available; Methods, results, and conclusions of studies carried out by the...

  • Fibrinolytic Factors in Liver Fibrosis. Liang-I. Kang; Mars, Wendy M. // Current Pharmaceutical Biotechnology;Sep2011, Vol. 12 Issue 9, p1441 

    Dysregulation of coagulation and fibrinolytic factors is now being recognized as not just a late-stage sequelae of liver disease, but in fact one of the potential contributing risk factors for liver cirrhosis. Recent molecular and animal studies have uncovered intriguing roles for plasmin and...

  • Hepatocyte growth factor incorporated chitosan nanoparticles augment the differentiation of stem cell into hepatocytes for the recovery of liver cirrhosis in mice. Pulavendran, Sivasami; Rose, Chellan; Mandal, Asit Baran // Journal of Nanobiotechnology;2011, Vol. 9 Issue 1, p15 

    Background: Short half-life and low levels of growth factors in the niche of injured microenvironment necessitates the exogenous and sustainable delivery of growth factors along with stem cells to augment the regeneration of injured tissues. Methods: Here, recombinant human hepatocyte growth...

  • The Hepatic Sinusoid in Aging and Cirrhosis: Effects on Hepatic Substrate Disposition and Drug Clearance. Couteur, David G. Le; Fraser, Robin; Hilmer, Sarah; Rivory, Laurent P.; McLean, Allan J. // Clinical Pharmacokinetics;2005, Vol. 44 Issue 2, p187 

    The fenestrated sinusoidal endothelium (‘liver sieve’) and space of Disse in the healthy liver do not impede the transfer of most substrates, including drugs and oxygen, from the sinusoidal lumen to the hepatocyte. Plasma components transfer freely in both directions through the...

  • Hepatocyte Produced Matrix Metalloproteinases Are Regulated by CD147 in Liver Fibrogenesis. Calabro, Sarah R.; Maczurek, Annette E.; Morgan, Alison J.; Tu, Thomas; Wen, Victoria W.; Yee, Christine; Mridha, Auvro; Lee, Maggie; d'Avigdor, William; Locarnini, Stephen A.; McCaughan, Geoffrey W.; Warner, Fiona J.; McLennan, Susan V.; Shackel, Nicholas A. // PLoS ONE;Jul2014, Vol. 9 Issue 7, p1 

    Background: The classical paradigm of liver injury asserts that hepatic stellate cells (HSC) produce, remodel and turnover the abnormal extracellular matrix (ECM) of fibrosis via matrix metalloproteinases (MMPs). In extrahepatic tissues MMP production is regulated by a number of mechanisms...

  • Changes in Serum Human Hepatocyte Growth Factor Levels after Transcatheter Arterial Embolization and Partial Hepatectomy. Kaneko, Akira; Hayashi, Norio; Tanaka, Yuji; Ito, Toshifumi; Kasahara, Akinori; Kubo, Mitsuhiko; Mukuda, Tomoyuki; Fusamoto, Hideyuki; Kamada, Takenobu // American Journal of Gastroenterology;Aug1992, Vol. 87 Issue 8, p1014 

    We examined the changes in serum human hepatocyte growth factor (hHGF), also called "scatter factor," levels after transcatheter arterial embolization (TAE) and partial hepatectomy (PH) in patients with hepatocellular carcinoma and metastatic liver tumor. In most cases, the serum hHGF levels...

  • Prognostic Impact of Surgical Complications and Preoperative Serum Hepatocyte Growth Factor in Hepatocellular Carcinoma Patients After Initial Hepatectomy. Mizuguchi, Toru; Nagayama, Minoru; Meguro, Makoto; Shibata, Toshihito; Kaji, Shinsuke; Nobuoka, Takayuki; Kimura, Yasutoshi; Furuhata, Tomohisa; Hirata, Koichi // Journal of Gastrointestinal Surgery;Feb2009, Vol. 13 Issue 2, p325 

    Introduction The relationship between postoperative complications and survival after hepatectomy is not completely understood. The purpose of this study was to determine if surgical complications would have a prognostic impact and to identify any difference of the prognostic factors between a...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics